INNOVATE BIOPHARMA CONSULTING LIMITEDActive
Key figures
Like most small UK companies, INNOVATE BIOPHARMA CONSULTING LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Total assets | 3,101 | 0 | 0 | 0 | 0 |
| Total liabilities | 0 | 0 | 0 | 0 | 0 |
| Net assets / total equity | 3,101 | 0 | 0 | 0 | 0 |
| Average number of employees | 1 | 0 | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: INNOVATE BIOPHARMA CONSULTING LIMITED
Company
INNOVATE BIOPHARMA CONSULTING LIMITED is a private limited company registered with Companies House under company number 12608089. It was incorporated on 18 May 2020. Its status is active. The registered office is in Farnham (GU9). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files micro-entity accounts. Net assets were £0. Total assets were £0 and total liabilities £0. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 21 May 2027.